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S U P P L E M E N T A R T I C L E
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Background. Invasive salmonelloses are a major cause of morbidity and mortality in Africa, but the incidence
and case fatality of each disease vary markedly by region. We aimed to describe the incidence, clinical characteristics,
and antimicrobial susceptibility patterns of invasive salmonelloses among children and adults in Kiliﬁ, Kenya.
Methods. We analyzed integrated clinical and laboratory records for patients presenting to the Kiliﬁ County
Hospital between 1998 and 2014. We calculated incidence, and summarized clinical features and multidrug resistance.
Results. Nontyphoidal Salmonella (NTS) accounted for 10.8% and 5.8% of bacteremia cases in children and adults,
respectively, while Salmonella Typhi accounted for 0.5% and 2.1%, respectively. Among 351 NTS isolates serotyped,
160 (45.6%) were Salmonella Enteritidis and 152 (43.3%) were Salmonella Typhimurium. The incidence of NTS in
children aged <5 years was 36.6 per 100 000 person-years, being highest in infants aged <7 days (174/100 000 per-
son-years). The overall incidence of NTS in children varied markedly by location and declined signiﬁcantly during
the study period; the pattern of dominance of the NTS serotypes also shifted from Salmonella Enteritidis to Salmonella
Typhimurium. Risk factors for invasive NTS disease were human immunodeﬁciency virus infection, malaria, and mal-
nutrition; the case fatality ratio was 22.1% (71/321) in children aged <5 years and 36.7% (11/30) in adults. Multidrug
resistance was present in 23.9% (84/351) of NTS isolates and 46.2% (12/26) of Salmonella Typhi isolates.
Conclusions. In Kiliﬁ, the incidence of invasive NTS was high, especially among newborn infants, but typhoid
fever was uncommon. NTS remains an important cause of bacteremia in children <5 years of age.
Keywords. Salmonella; nontyphoidal; Typhi; incidence; Kenya.
Estimates of the burden of invasive Salmonella infec-
tions in sub-Saharan Africa are limited by the scarcity
of regional data. The global burden of typhoid fever
was estimated at 26.9 million cases in 2010 [1], but
only Egypt and South Africa contributed to this esti-
mate for the African continent. Within Africa, surveil-
lance from Kenya, Tanzania, Malawi, and South Africa
has shown marked regional variation in the incidence
and age-speciﬁc patterns of typhoid fever [2–4]. Ty-
phoid fever is caused by Salmonella enterica serovar
Typhi, whereas nontyphoidal Salmonella (NTS) disease
refers to infections caused by Salmonella enterica sero-
vars other than Typhi and Paratyphi A.
The burden of NTS disease in Africa is even less well
understood. In high-income countries, NTS causes a
self-limiting gastroenteritis and is transmitted though
contaminated food. In contrast, infection with NTS in
Africa is usually invasive, causing severe life-threatening
sepsis. In fact, NTS is a common cause of bacteremia in
both children and adults [5, 6]. In a study of community-
acquired bloodstream infections across Africa, NTS
was the most common pathogenic isolate in adults;
in children, it was the second most common, after
Streptococcus pneumoniae [6]. Risk factors for invasive
NTS (iNTS) disease include malaria infection, human
immunodeﬁciency virus (HIV), and malnutrition
[5, 7], all of which have a high prevalence in Africa. Ex-
isting estimates of the incidence of iNTS are derived
mainly from children and high-risk groups [5, 8–10].
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Population-based studies are few and thus incidence estimates
are extremely limited. Modeled estimates of iNTS infection,
based on extrapolations from these studies, adjusting for the ef-
fects of HIV and malaria, suggest an incidence in Africa of 227
cases per 100 000 per year across all age groups, with a case fa-
tality rate of 20% [11].
Although incidence estimates are scarce, NTS repeatedly rank
near the top in series of invasive pathogenic bacteria on the con-
tinent, suggesting that they are a cause of considerable morbidity
and mortality. Vaccines are available to protect against Salmonel-
la Typhi infections and are in development to prevent NTS. The
case for vaccine development, and the proper evaluation and de-
ployment of such vaccines in Africa, depends upon a sound un-
derstanding of the epidemiology of the disease in different parts
of the continent. This study describes the incidence, clinical char-
acteristics, and antimicrobial susceptibility patterns of invasive
salmonellosis among children and adults admitted to Kiliﬁ
County Hospital in Coastal Kenya.
METHODS
This is a retrospective analysis of integrated demographic, clin-
ical, and microbiological surveillance data accumulated at the
Kenya Medical Research Institute (KEMRI)–Wellcome Trust
Research Programme over a period of 16 years from August
1998 through December 2014 for children ≤14 years of age,
and from January 2007 through December 2014 for adults
>14 years of age.
Study Population
The study was undertaken in Kiliﬁ County, a rural area 3 degrees
south of the equator on the Indian Ocean coast, typical of much of
tropical sub-Saharan Africa. Kiliﬁ County Hospital (KCH) is locat-
ed at the center of the Kiliﬁ Health and Demographic Surveillance
System (KHDSS), which was established in 2000 to monitor births,
deaths, in-migration, and out-migration in a population of ap-
proximately 280 000 over an area of 891 km2 [12]. Events are mon-
itored at KCH and through routine home visits every 4 months.
Since August 1998, all children (≤14 years of age) admitted to
KCH, except those admitted for elective procedures or observations
after minor accidents, have been investigated with blood cultures
routinely on admission [5]. Full blood counts and microscopy
for malaria parasites were also analyzed routinely. Clinical and lab-
oratory data have been systematically recorded on a standard pro
forma [13].Treatment was offered according to local protocols and
current World Health Organization recommendations [14].
Meningitis was suspected where 1 or more of the following
signs were present: stiff neck, bulging fontanelle, lethargy, loss
of consciousness, prostration or history of convulsions (except
febrile convulsions), and signs of sepsis in neonates. Lumbar
punctures were performed for these cases. Malnutrition was
deﬁned as a weight-for-age z score of≤− 3. Severe pneumonia
was deﬁned as history of cough or difﬁculty breathing plus
lower chest wall indrawing, and very severe pneumonia was
deﬁned as cough or difﬁculty breathing plus either hypoxia,
lethargy, loss of consciousness, prostration, or a history of
convulsions.
A similar approach for surveillance in adults was established
in January 2007. Blood cultures were taken for all patients pre-
senting to the wards with a history of fever, axillary temperature
of <36°C or >37.4°C, or signs of focal sepsis. Cerebrospinal ﬂuid
(CSF) cultures were taken in patients with any 2 of pyrexia (ax-
illary temperature >37.4°C), meningism (neck stiffness and/or
photophobia), or altered mental status.
A case was deﬁned as a patient in whom Salmonella enterica
species was cultured from blood or CSF.
Procedures
Pediatric blood samples for bacterial cultures were collected in
BACTEC Peds Plus bottles and processed with a BACTEC au-
tomated blood culture instrument (Becton Dickinson) for ini-
tial detection of bacteria in the blood. In adults, BACTEC Plus
Aerobic/F bottles were used. BACTEC-positive samples were
subcultured on standard media by routine microbiological tech-
niques. Either biochemical test kits (API, bioMérieux), serolog-
ical tests, or both were used to conﬁrm suspected pathogens.
Good Clinical Laboratory Practice was audited by Qualogy
and external quality assurance was provided by the UK National
External Quality Assessment service.
The following organisms were considered as contaminants:
Bacillus species, coryneforms, Micrococcus species, coagulase-
negative Staphylococcus, and viridans group Streptococcus. Sal-
monella serotypes were determined using the Kauffman–White
scheme and commercial antisera. Antimicrobial susceptibilities
were determined by broth dilution using Microscan panels (Sie-
mens, Germany), and minimum inhibitory concentrations were
interpreted using the latest Clinical and Laboratory Standards
Institute guidelines [15]. Organisms that showed intermediate
susceptibility results to any of the drugs tested were labeled as
nonsusceptible to the drug. Multidrug resistance (MDR) was
deﬁned as nonsusceptibility to ≥2 of the following antibiotics:
ampicillin, trimethoprim-sulfamethoxazole (cotrimoxazole),
and tetracycline.
An automated counter (Beckman Coulter for children, Coul-
ter ACT-5 for adults) measured blood counts and hemoglobin.
Blood was examined for malaria parasites by Giemsa-stained
thick and thin ﬁlms at ×1000 magniﬁcation. Systematic HIV-
1 testing was performed using rapid antibody tests according
to national policy, which began in 2007 [16]. Prior to that,
HIV testing was undertaken only in those seeking a result.
DNAwas extracted retrospectively from frozen samples collect-
ed at admission by use of Qiagen DNA blood mini-kits (Qiagen,
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Crawley, United Kingdom) and typed for sickle cell anemia by
polymerase chain reaction.
Statistical Analysis
Student t test or Wilcoxon rank-sum test were conducted for
normal or nonnormally distributed continuous variables, re-
spectively. We used logistic regression to establish the risk fac-
tors for NTS bacteremia compared to other admissions.
Variables that were signiﬁcant (P < .1) in the univariate analysis
were included in the multivariable model. Odds ratios (ORs)
and 95% conﬁdence intervals (CIs) were reported.
Incidence was calculated among the residents of the KHDSS
using the midyear population estimates as the denominator.
Age-speciﬁc population estimates for the era before the
KHDSS began were extrapolated using a log linear model of
age-speciﬁc data based on subsequent enumerations. We ad-
justed the incidence to account for the proportion of patients
who were eligible for blood cultures but missed them and for
the proportion of cultures that were contaminated, assuming
the distribution of true pathogens in contaminated vials was
represented by the distribution in uncontaminated vials. In
adults, we estimated the proportion of the KHDSS that was
HIV infected using the population prevalence for Coast Prov-
ince (4.3%) [17] and used this as a denominator in calculating
the incidence of iNTS among HIV-infected individuals.
Hospital-based surveillance has been associated with under-
ascertainment of cases illustrated by distance decay in the inci-
dence of admissions to hospital in patients aged <5 years [18].
We adjusted the incidence of NTS for underascertainment in
the number of patients presenting to KCH among children <5
years. We assumed that the true incidence of hospitalization
with NTS infection in each location was proportional to the lo-
cation-speciﬁc death rates in the KHDSS and that the location
closest to the hospital (Kiliﬁ Township) had complete ascertain-
ment [18]. The analysis was performed using Stata 13 (Stata-
Corp, College Station, Texas).
Ethical Approval
We report results from a series of research studies that were ap-
proved by the National Ethical Review Committee of KEMRI
(scientiﬁc steering committee 1067, 1357, and 1433). Patients
were only investigated if we obtained informed written consent
either from the patient or, in the case of children, from their
parent or guardian.
RESULTS
Bacterial Isolation and Typing
Of 75 676 admissions among children, 3296 had bacteremia of
which 357 (10.8%) were NTS and 15 (0.5%) were Salmonella
Typhi isolates (Figure 1). Among 22 924 adult admissions,
521 had bacteremia, of which 30 (5.8%) were NTS and 11
(2.1%) were Salmonella Typhi isolates. Of 387 isolates of NTS,
351 were serotyped; 160 (45.6%) were Salmonella enterica sero-
var Enteritidis, 152 (43.3%) were Salmonella enterica serovar
Typhimurium, and 39 (11.1%) isolates could not be serotyped
using the panel of antisera available. There were no Salmonella
Paratyphi organisms isolated. There was 1 case of Salmonella
enterica subspecies arizonae that was excluded from this
analysis.
Twenty-two isolates of NTS were cultured from CSF samples
taken on admission; 8 (36.4%) occurred in neonates <7 days old
and all of them occurred in infants. Among these 22 infants, 19
(86.4%) had blood cultures positive for NTS. There were no
cases of NTS meningitis in adults. Salmonella Typhi was not
isolated from CSF in either children or adults.
Mixed infections with NTS were present in 10 patients, of
whom 5 were coinfected with S. pneumoniae; the others had
group A Streptococcus (3), Escherichia coli (1), and Pseudomo-
nas species (1).
Age and Sex Distribution
Among children and adults combined, the median age of infec-
tion with iNTS was 1 year (interquartile range [IQR], 0–3 years)
and with Salmonella Typhi was 8.5 years (IQR, 2–18 years).
Among children, 199 of 357 (55.7%) patients with iNTS
and 9 of 15 (60%) with Salmonella Typhi were male. The me-
dian age of children with iNTS was 15 months (IQR, 7–28
months) and with Salmonella Typhi was 34 months (IQR,
28–77 months).
Among adults, 11 of 30 (36.7%) patients with iNTS and 8 of
11 (72.7%) with Salmonella Typhi were male. The median age
of infection with iNTS and with Salmonella Typhi was 30 years
(IQR, 24–42 years) and 22 years (IQR, 18–39 years), respective-
ly. The median age of infection with iNTS did not vary by sex.
There were no differences in the serotype distribution across
different age groups.
Clinical Characteristics and Risk Factors for Invasive NTS
Disease
Among children with iNTS, 261 of 351 (74.4%) presented with
fever (axillary temperature >37.4°C), 99 of 352 (28.1%) had
Plasmodium falciparum infection on their blood slide, 19 of
268 (7.1%) had sickle cell disease, and 60 of 249 (24.1%) were
HIV infected. Signiﬁcant risk factors were elevated temperature,
malnutrition, splenomegaly, and HIV infection (Table 1).
Among 30 adults with NTS bacteremia, only 12 (40.0%)
presented with a febrile illness and none were infected with
P. falciparum. HIV infection was present in 21 of the 23 (91.3%)
patients tested. In the ﬁnal model, signiﬁcant risk factors for
iNTS infection were HIV (OR, 20.4 [95% CI, 4.67–89.21])
and diarrhea (OR, 4.34 [95% CI, 1.88–10.02]).
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Recurrent infection was observed in only 1 female HIV-
infected adult admitted with NTS bacteremia, 6 months after
the ﬁrst admission. The serotype isolated was Salmonella Typhi-
murium in both admissions.
Incidence
There were 219 cases of iNTS and 13 cases of Salmonella Typhi
occurring in residents of the KHDSS, representing 57% and
50% of all hospitalized cases, respectively. The incidence of
Figure 1. Consolidated Standards of Reporting Trials (CONSORT) diagram representing ﬂow of patients. A, Children. B, Adults. Abbreviations: CSF,
cerebrospinal ﬂuid; NTS, nontyphoidal Salmonella.
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iNTS among children aged <5 years was 25.6 per 100 000 per-
son-years of observation (PYO). The rate adjusted for missing
specimens and contaminated cultures was 32.6 (95% CI, 28.1–
37.7) and the rate adjusted, in addition, for access to care was
36.4 per 100 000 PYO (Table 2). The incidence varied by age (Fig-
ure 2B) but was highest among newborn infants <7 days old at
Figure 1 continued.
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174.4 per 100 000 PYO (crude incidence, 136.6 per 100 000 PYO).
Variation across the locations of the KHDSS was marked (range,
4.8–69.8 per 100 000 PYO), with the highest rates from locations
south of KCH (Figure 2C). By Poisson regression, the incidence of
iNTS among children aged <5 years declined, on average, by 16%
in each year of the study period (incidence rate ratio [IRR], 0.84
[95% CI, .81–.86]) whereas the incidence of Salmonella Typhi
bacteremia remained constant (IRR, 1.05 [95% CI, .90–1.22]).
In children, the incidence of Salmonella Typhimurium and Sal-
monella Enteritidis in children declined by 14% (IRR, 0.86
[95% CI, .81–.90]) and 21% (IRR, 0.79 [95% CI, .74–.83]) per
year, respectively (Supplementary Figure 1).
In adults, the adjusted incidence of iNTS was 1.7 per 100 000
PYO. Among HIV-infected individuals, the crude incidence of
iNTS was 13.2 per 100 000 PYO compared with a crude inci-
dence of 0.1 per 100 000 PYO among HIV-uninfected individ-
uals (IRR, 133.5 [95% CIs, 16.2–6142.4]). The incidence of
iNTS in adults did not vary signiﬁcantly by time. For Salmonella
Typhi infections, the incidence among children and adults was
0.4 and 0.5 per 100 000 PYO, respectively.
Antimicrobial Susceptibility
Among 351 NTS isolates, in vitro resistance to ampicillin,
trimethoprim-sulfamethoxazole, tetracycline, and cefotaxime
Table 1. Characteristics of Patients Presenting With Invasive Nontyphoidal Salmonella Disease and Associated Risk Factors in Children
and Adults
Characteristic
NTS Bacteremia, No.
Positive/No. Tested (%)
Other Admissions,
No. Positive/
No. Tested (%)
Unadjusted OR
(95% CI) P Value
Adjusted OR
(95% CI) P Value
Children n = 357 n = 75 676
Clinical features
Sex, male 199 (55.7) 42 495/75 676 (56.4) 0.96 (.78–1.17) .667
Temperature
Low 24/351 (6.9) 11 070/74 361 (14.9) 0.78 (.49–1.21) .271 0.24 (.07–.80) .020
Normal 66/351 (18.8) 22 792/74 361 (30.7)
High 261/351 (74.4) 40 499/74 361 (54.5) 2.17 (1.66–2.82) <.001 2.03 (1.27–3.28) <.001
Diarrhea 103/344 (29.9) 13 739/72 561 (18.9) 1.88 (1.50–2.36) <.001
Vomiting 110 (32.0) 19 121/73 396 (26.1) 1.33 (1.06–1.67) .012
Malnutrition 103 (31.4) 12 619/70 584 (17.9) 2.16 (1.71–2.71) <.001 2.25 (1.47–3.44) <.001
Severe pneumonia 61 (17.1) 12 563/75 676 (16.8)
Very severe 60 (16.9) 10 324/75 676 (13.8) 1.2 (.84–1.71) .319
Pneumonia
Splenomegaly 40 (19.0) 3351/56 026 (6.0) 3.66 (2.60–5.15) <.001 4.61 (2.70–7.86) <.001
Hepatomegaly 37 (17.6) 4133/56 027 (7.4) 2.67 (1.88–3.79) <.001
Laboratory features
Malaria slide positive 99/352 (28.1) 18 645/71 973 (25.9) 1.08 (.85–1.36) .532
HIV positive 60/249 (24.1) 1998/31 077 (6.4) 4.53 (3.39–6.06) <.001 5.16 (3.29–8.07) <.001
Adults n = 30 n = 22 894
Clinical features
Sex, male 11 (36.7) 9846/22 894 (43.0) 0.77 (.36–1.61) .485
Temperature
Low 9 (30.0) 7336/21 339 (34.4) 1.37 (.54–3.46) .501
Normal 9 (30.0) 10 076/21 339 (47.2) 1
High 12 (40.0) 3927/21 339 (18.4) 3.42 (1.44–8.13) .005
Diarrhea 14 (46.7) 1604/21 541 (7.4) 10.88 (5.30–22.32) <.001 4.34 (1.88–10.02) .001
Vomiting 12 (40.0) 2501/21 542 (11.6) 5.08 (2.44–10.55) <.001
Splenomegaly 2 (6.7) 217/21 527 (1.0) 7.01 (1.66–29.63) .008
Hepatomegaly 5 (16.7) 762/21 528 (3.5) 5.45 (2.08–14.28) .001
Laboratory features
Malaria slide positive 0/24 (0) 251/7771 (3.2) 1.00 (1.00–1.00)
HIV positive 21/23 (91.3) 2583/9351 (27.6) 27.51 (6.45–117.42) <.001 20.41 (4.67–89.21) <.001
Abbreviations: CI, confidence interval; HIV, human immunodeficiency virus; NTS, nontyphoidal Salmonella; OR, odds ratio.
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was observed in 98 (27.9%), 86 (24.5%), 35 (10.0%), and 21
(6.0%), respectively (Supplementary Table 1). Eighty-four
(23.9%) of the NTS isolates were MDR. Of the 21 patients show-
ing nonsusceptibility to third-generation cephalosporins, 8
(38.1%) died during the admission.
Among the NTS serotypes, resistance to individual drugs was
mainly driven by Salmonella Typhimurium, which also had a
higher percentage of MDR isolates (55/152 [36.2%]). Twenty
of the 21 isolates showing nonsusceptibility to third-generation
cephalosporins were Salmonella Typhimurium. Multidrug
resistance in iNTS serotypes showed temporal variability with
several peaks across the years. A peak in MDR Salmonella
Typhimurium in 2005 was followed sequentially by a shift in
dominance over Salmonella Enteritidis (Figure 3). Peaks in
MDR isolates of Salmonella Enteritidis were seen over time
with no apparent change in the proportion of isolates in subse-
quent years.
Of Salmonella Typhi, 12 of 26 (46.2%) were MDR. Eight
(66.7%) of these MDR isolates were isolated in 1 year (2007).
Salmonella Typhi isolates were all susceptible to cefotaxime.
Case Fatality Ratio (CFR)
Among 321 cases of iNTS disease in children aged <5 years, 71
(22.1%) died in hospital (Table 2). The CFR for newborn in-
fants <7 days old was 57.1% (4/7) and for NTS meningitis
was 45.5% (10/22). Among 10 children with mixed infections
of NTS and another pathogen, 6 died in hospital. Among adult
cases of iNTS, 11 of 30 (36.7%) died in hospital. Among 26 pa-
tients of all ages with Salmonella Typhi bacteremia, 1 (3.8%)
adult died.
DISCUSSION
We describe the characteristics of 387 cases of iNTS disease and
26 cases of Salmonella Typhi diagnosed in a rural hospital in
Kenya. The importance of NTS as a cause of bacteremia in chil-
dren has been previously described in this setting and other
countries in Africa [5, 6, 10, 19]. Newborns and infants are
those most susceptible to iNTS [5, 20] and in our study had
the highest CFRs; more than half of all infected newborn infants
died during the hospital admission.
Our results show a decrease in the incidence of iNTS over time
in children. This is most likely associated with the decline in ma-
laria infections over the same period [21].The association of NTS
with recent or current malaria has been repeatedly documented in
children [22–24]. In our analysis, current malaria infection was
not signiﬁcantly associated with iNTS infection but splenomegaly,
a marker of recent malaria infection, was. Malnutrition and HIV
infection were independent risk factors of iNTS infection.
In previous studies, sickle cell anemia has been shown to be
strongly associated with iNTS disease [25].Among our pediatric
cases with iNTS, the prevalence of sickle cell anemia was 7.1%
compared with a prevalence of 1% in a birth cohort of >10 000
children recruited during the same period in Kiliﬁ and investi-
gated in infancy [21]. None of the cases of Salmonella Typhi
tested had sickle cell anemia.
Among adults, HIV was the principal risk factor for iNTS
disease. The incidence of iNTS among HIV-infected patients
was 133 times higher than among HIV-uninfected individuals.
In an area with a HIV prevalence of 4.3%, this is highly signiﬁ-
cant. Among adults, iNTS disease was more common in females
than in males, reﬂecting the higher prevalence in women (6.1%)
than in men (2.6%) in Kenya [17].None of the adult cases had a
positive malaria slide, although the adult surveillance was only
established in 2007 when the prevalence of malaria in Kiliﬁ had
already fallen substantially [21].
Only 1 adult case of Salmonella Typhi infection was HIV in-
fected. Similar low prevalence of HIV in cases of Salmonella
Typhi has been shown in studies from Tanzania [26, 27]. The
incidence of Salmonella Typhi across all age groups was 0.5
per 100 000 PYO, which yielded insufﬁcient cases in which to
examine risk factors. In addition, the CFR for typhoid fever
in hospital was low at 1 in 26 (3.8%). Although the majority
of the Salmonella Typhi cases reported here were in children
(58%), there were no deaths in children. Culture-conﬁrmed Sal-
monella Typhi infections in Africa are less common than NTS
Table 2. Crude and Adjusted Incidence Rates and Case Fatality Rate of Invasive Nontyphoidal Salmonella Disease Across Different Age
Groups
Age
Group, y Cases Deaths CFR (%)
Cases in
KHDSS
Person-years
of Observation
Crude Incidence
(95% CI)
Adjusted Incidencea
(95% CI)
Access-Adjusted
Incidence (95% CI)
0–4 321 71 22 186 726 881 25.6 (22.0–29.5) 32.6 (28.1–37.7) 36.4 (35.6–37.1)
5–14 36 3 8.3 22 1 174 129 1.9 (1.17–2.84) 2.4 (1.49–3.62) . . .
≥15 30 11 37 11 1 056 038 1.0 (.52–1.86) 1.7 (.87–3.11) . . .
Incidence rates are given per 100 000 person-years.
Abbreviations: CFR, case fatality rate; CI, confidence interval; KHDSS, Kilifi Health and Demographic Surveillance System.
a Adjustment based on missed blood cultures and contamination rate per age group.
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infections but are especially associated with urban areas with
poor hygiene and sanitation [2, 6]. Salmonella Typhi infections
commonly occur in epidemics [28, 29]. In our study, we
retrospectively identiﬁed a small outbreak of MDR Salmonella
Typhi that occurred in 2007–2008 that was associated with 1
death.
Figure 2. A, Crude incidence (and 95% conﬁdence intervals [CIs]) of nontyphoidal (NTS) bacteremia among children (<15 years) across the study period. B,
Crude age-incidence curve (and 95% CIs) of NTS bacteremia among children.
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Previous reports from Kiliﬁ have shown higher susceptibility
to amoxicillin and cotrimoxazole among iNTS isolates com-
pared with Escherichia coli and other gram-negative bacilli by
Etest [30]. This general susceptibility to common antibiotics
was seen in our study, with the prevalence of MDR declining
over time. The majority of the MDR isolates were Salmonella
Figure 2 continued. C, Map of the Kiliﬁ Health and Demographic Surveillance System showing geographical distribution of the access-adjusted rates of
NTS bacteremia among children aged <5 years. Abbreviation: PYO, person-years of observation.
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Typhimurium. These could be the distinct genotype ST313
that has been identiﬁed among MDR Salmonella Typhimurium
causing invasive disease in Kenya and Malawi [31]; unfortu-
nately, because we were unable to do multilocus sequence
typing, this cannot be conﬁrmed. The presence of resistance
to third-generation cephalosporins among iNTS is alarming
and we intend to characterize these isolates further. In low-
income countries, extended MDR NTS infections have
limited options for alternative therapy, especially among those
who are HIV infected [32], and are associated with high
mortality.
With incomplete access to care and low blood culture sensi-
tivity for iNTS, the incidence at population level is difﬁcult to
measure and is often underestimated as a consequence. We
show a marked variation in the incidence by location, with
the locations further from KCH having the lowest incidence.
However, after adjusting for access to care, the incidence esti-
mate for iNTS admissions among <5-year-olds increased by
only 12%, suggesting that for a disease as severe and potentially
fatal as iNTS, the barriers to hospital admission are compara-
tively small.
We have reported one of the longest series of continuous sur-
veillance for invasive bacterial disease in sub-Saharan Africa
using consistent demographic, clinical, and laboratory methods.
In a rural setting with a high burden of malaria initially and a
low prevalence of HIV infection, we have observed a high inci-
dence of iNTS disease among children and a low incidence of
typhoid fever. The burden of iNTS in children has declined in
synchrony with the dramatic reduction in malaria parasitemia
in the study area. However, over the whole period it was the sec-
ond commonest cause of invasive bacterial infection and had a
CFR of 23% in children <5 years of age. It is an especially fatal
disease in newborn infants. Theories linking malaria to iNTS
disease in children do not readily explain the high risk of disease
in neonates who do not often get malaria. As pneumococcal
disease is brought under control by vaccination, invasive NTS
disease may become the most important cause of sickness
and death due to invasive bacterial infections in children in
Figure 3. The relationship between multidrug resistance (MDR) and the number of nontyphoidal Salmonella (NTS) and Salmonella Typhi (A) or the num-
ber of NTS isolates per serotype (B) among children, August 1998–2014.
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Kiliﬁ, and a common disease of adults. Public health measures
to control NTS disease and its transmission, possibly including
effective vaccination, are likely to improve child and adult
health in the region.
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